The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 3, 2012, Pages 177-181

  Murray, Vincent ^a   Kandasamy, Niruba ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Capillary electrophoresis; Cisplatin; Consecutive guanines; Linear amplification; Polymerase stop assay; Sequence specificity; Telomeres

Indexed keywords

CISPLATIN; GUANINE; REPETITIVE DNA;

ARTICLE; CLONE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA SEQUENCE; FLUORESCENCE; GENE AMPLIFICATION; GENOMICS; QUANTITATIVE ANALYSIS;

EID: 84857763137     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012800228742     Document Type: Article

References (20)

1. Loehrer, P.J.; Einhorn, L.H. Drugs five years later. Cisplatin. Ann. Intern. Med., 1984, 100, 704-713.
2. Kelland, L.R. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer, 2007, 7, 573-584.
3. Fichtinger-Schepman, A.M.; van der Veer, J.L.; den Hartog, J.H.; Lohman, P.H.; Reedijk, J. Adducts of the antitumor drug cisdiamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry, 1985, 24, 707-713.
4. Wang, D.; Lippard, S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov., 2005, 4, 307-320.
5. Jung, Y.W.; Lippard, S.J. Direct cellular responses to platinuminduced DNA damage. Chem. Rev., 2007, 107, 1387-1407.
6. Ponti, M.; Forrow, S.M.; Souhami, R.L.; D'Incalci, M.; Hartley, J.A. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucl. Acids Res., 1991, 19, 2929-2933.
7. Murray, V.; Motyka, H.; England, P.R.; Wickham, G.; Lee, H.H.; Denny, W.A.; McFadyen, W.D. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. J. Biol. Chem., 1992, 267, 18805-18809.
8. Murray, V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on anti-tumour agents. (Review). Prog. Nucl. Acid Res. Mol. Biol., 2000, 63, 367-415.
9. Temple, M.D.; Recabarren, P.; McFadyen, W.D.; Holmes, R.J.; Denny, W.A.; Murray, V. The interaction of DNA-targeted 9- aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells. Biochim. Biophys. Acta, 2002, 1574, 223-230.
10. Viscardi, V.; Clerici, M.; Cartagena-Lirola, H.; Longhese, M.P. Telomeres and DNA damage checkpoints. Biochimie, 2005, 87, 613-624.
11. Henderson, E.R.; Blackburn, E.H. An overhanging 3' terminus is a conserved feature of telomeres. Mol. Cell. Biol., 1989, 9, 345-348.
12. Cesare, A.J.; Reddel, R.R. Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet., 2010, 11, 319-330.
13. Moyzis, R.K.; Buckingham, J.M.; Cram, L.S.; Dani, M.; Deaven, L.L.; Jones, M.D.; Meyne, J.; Ratliff, R.L.; Wu, J.R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA, 1988, 85, 6622-6626.
14. Burstyn, J.N.; Heiger-Bernays, W.J.; Cohen, S.M.; Lippard, S.J. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent. Nucl. Acids Res., 2000, 28, 4237-4243.
15. Paul, M.; Murray, V. Use of an Automated Capillary DNA Sequencer to Investigate the Interaction of Cisplatin with Telomeric DNA Sequences. Biomed. Chromat. in press - DOI 10.1002/bmc.1664.
16. Paul, M.; Murray, V. The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence. J. Biol. Inorgan. Chem., 2011, 16, 735-743.
17. Galea, A.M.; Murray, V. The Anti-tumour Agent, Cisplatin, and its Clinically Ineffective Isomer, Transplatin, Produce Unique Gene Expression Profiles in Human Cells. Cancer Informat., 2008, 6, 315-355.
18. Murray, V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucl. Acids Res., 1989, 17, 8889.
19. Mattes, W.B.; Hartley, J.A.; Kohn, K.W. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucl. Acids Res., 1986, 14, 2971-2987.
20. White, R.J.; Phillips, D.R. Sequence-dependent termination of bacteriophage T7 transcription in vitro by DNA-binding drugs. Biochemistry, 1989, 28, 4277-4283.